Agoracom Blog Home

Posts Tagged ‘#psychedelic’

Red Light Holland’s $TRIP.ca Science and Innovation Division, Scarlette Lillie, Announces Collaboration with Jinfiniti Precision Medicine to Pursue Clinical Study Insights $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM-Eric at 8:47 AM on Wednesday, September 30th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png
  • Scarlette Lillie Science and Innovation has secured a relationship with Jinfiniti Precision Medicine
  • Exploring the potential roles that psilocybin and truffles can play for age-related and psychiatric disorders

Toronto, Ontario–(Newsfile Corp. – September 30, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that its science division, Scarlette Lillie Science and Innovation (“Scarlette Lillie“), has secured a relationship with Jinfiniti Precision Medicine (“Jinfiniti“) in order to explore the potential roles that psilocybin and truffles can play for age-related and psychiatric disorders. Jinfiniti has created a world class “AgingSOS” test panel that can detect key factors from blood that drive aging and other genetic instabilities. The speed and affordability of this test can allow for both company’s Scientists to clearly evaluate the potential for psilocybin treatments that go beyond what is currently being explored. The CEO of Jinfiniti is Dr. Jin-Xiong She, a professor at Augusta University in Georgia, USA, whose expertise is in the creation of biomarker panels. Jinfiniti’s state of the art panel is making it possible to extend the applicability of psilocybin.

“We are pleased to work with Scarlette Lillie, and we are excited to add this special dimension to their clinical study explorations as they emerge,” says Dr. She, CEO of Jinfiniti.

“The idea that psilocybin and truffles have deep physiological and medicinal effects that go beyond psychiatric applications is not new, but as a scientist, Scarlette Lillie is allowing me to truly explore whole new markets, with a rigorous biomarker panel. Additionally, this work has the potential to help us understand if there are unknown mechanisms at play for neurological and psychiatric disorders,” says Dr. Joseph Geraci, CEO of NetraMark Corp. and a scientific advisor to Red Light Holland. Dr. Geraci is helping to establish several clinical programs. He brings a deep knowledge of systems biology, medical science, and artificial intelligence to the team.

This relationship with Jinfiniti will allow Scarlette Lillie to add a novel component to expected clinical studies for psilocybin and truffles. The knowledge that comes from this has the potential to not only influence the outcome of clinical studies but can also potentially lead to novel treatments for several disorders.

“When you see brilliant Scientists like Dr. Joseph Geraci and Dr. Jin-Xiong She, a professor at Augusta University, show this much excitement, it gets me really excited!” Added Todd Shapiro, CEO and Director of Red Light Holland. “I’ve always made it very clear that as a company we take Science and Innovation very seriously. This is just another example of Scarlette Lillie moving forward intelligently with world class experts to hopefully help be a part of positive change.”

About Jinfiniti Precision Medicine

Jinfiniti is a precision medicine company that aims to increase the human healthspan. Using measures of key blood biomarkers, Jinfiniti is able to provide a detailed overview of individual aging health. Composed of researchers who met at the Medical College of Georgia, the Jinfiniti team is dedicated to the prevention of chronic disease and the promotion of longevity. Their novel approach to anti-aging practices involves conducting lab tests to measure aging biomarkers within the blood. This information then helps to guide individual lifestyle adjustments, leading to improved health and quality of life.

Jin-Xiong She, Ph.D., Professor at Augusta University
Founder & CEO
Jinfiniti Precision Medicine, Inc.
1120 15th Street, Augusta, GA 30912

About Red Light Holland Corp.

RLH is an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws. The Company’s brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops as well as its e-commerce platform, and are expected to be initially made available in the form of its previously announced Microdosing Packs.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer and Director
Tel: 647-204-7129

Email: [email protected]
Website: https://redlighttruffles.com

Red Light Holland $TRIP.ca iMicrodose Video with Todd Shapiro $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Posted by AGORACOM-Eric at 11:15 AM on Monday, September 28th, 2020
https://twitter.com/iamtoddytickles/status/1310565767038078979?s=21

Red Light Holland $TRIP.ca Reaches Distribution Agreement for iMicrodose Packs $IPO $SHRM.ca $RVV.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM-Eric at 8:47 AM on Monday, September 28th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png
  • iMicrodose Packs powered by Red Light Holland are expected to be available early October 2020
  • Creating a iMicrodose Media Information Centre (“iMIC“) in Super Smart’s Tiel location, expected to be ready before the end of 2020

Toronto, Ontario–(Newsfile Corp. – September 28, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce their iMicrodose Packs (“iMicrodose Packs“) powered by Red Light Holland are expected to be available early October 2020 in PharmaDrug Inc.’s (“PharmaDrug”) wholly-owned subsidiary Interrobang Ltd.’s (doing business as Super Smart) (“Super Smart“) store in Tiel, The Netherlands, as Red Light Holland has reached a distribution agreement with Super Smart.

Red Light Holland has also reached an agreement with Super Smart to build and set up an iMicrodose Media Information Centre (“iMIC“) in Super Smart’s Tiel location, expected to be ready before the end of 2020.

“Super Smart’s vision and iMicrodose’s vision truly align,” said Todd Shapiro, CEO and Director of Red Light Holland. “Both companies are focused on educating, informing and modernizing the psychedelic industry within the Netherlands. We are very excited to soon have another store where our product is sold to expand our exposure and marketplace. Equally as important, we are proud to set up our first iMicrodose Media Information Centre – iMIC – where we plan on eventually providing Super Smart with our Virtual Reality Headset where consumers can truly learn about our iMicrodose packs and the origins of the product, as well as hope to receive important customer feedback, as we want to give all consumers a voice for important information gathering and responsible-use feedback via our planned iMIC activation.”

“Red Light Holland has definitely already taken initial steps to modernize the industry, in the Netherlands, and we are so pleased to reach an agreement to house their responsible use product in our Tiel, Location, expected in Early October, 2020,” added Dan Cohen, CEO of PharmaDrug. “Together we want to elevate the industry, educate consumers and intelligently target all Adult Demographics for potential increased sales via new customers with an informational, technological and modern approach.”

Super Smart’s Tiel location is located in Central Netherlands and is the only smart shop within a 75 kilometre radius. iMicrodose Packs powered by Red Light Holland are expected to be in Smart Shop’s Tiel store in October, 2020.

https://orders.newsfilecorp.com/files/2017/64718_a8f225a094f53bdb_001full.jpg

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Red Light Holland’s $TRIP.ca iMicrodose Packs Are Now Available For Purchase In Stores and Online In The Netherlands Plus Launch Event and Livestream Update $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Posted by AGORACOM-Eric at 10:25 AM on Friday, September 25th, 2020

Toronto, Ontario–(Newsfile Corp. – September 25, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce their iMicrodose Packs (“iMicrodose Packs“) powered by Red Light Holland are now available in stores and online for purchase in the Netherlands. Red Light Holland would also like to update the time for their launch event of iMicrodose (the “iMicrodose Launch Event“), Microdosing Packs, in the Netherlands from 5-8pm (CEST) today (Friday, September 25th, 2020) with a global livestream starting at approximately 6:30pm and ending around 7:00pm (CEST) / 12:30-1:00pm (EST). The Global Livestream will be made available at:

glsr.live/iMicrodose and/or www.RedLightTruffles.com

“We are so proud. Our small team, including our President Hans Derix, have all worked extremely hard to get us to this momentous day for the company. Seriously, this is truly a magical day. On May 28th, I went on record saying Red Light Holland would aim to have product on shelves by the end of Q3, 2020. We have delivered and achieved that goal,” said Todd Shapiro, Chief Executive Officer and Director of the Company. “Today, from 5-8pm (CEST) at our iMicrodose Launch Event we will celebrate this first big win, but we recognize it’s just an initial step in our overall business plan and ultimate growth strategy in both building a responsible use recreational brand while continuing to develop our Science and Innovation division.”

Pictured: iMicrodose Packs powered by Red Light Holland

Red Light Holland’s iMicrodose Packs are now available for purchase in The Netherlands (18+) at www.iMicrodose.nl and currently at the following locations: (i) two Tatanka locations (ii) the Headshop and (iii) plus Tatanka’s website at www.tatanka.nl

Update: The iMicrodose Launch Event time has been updated and will be held today Friday, September 25th, 2020, in Amsterdam at the A’DAM the Loft from 5-8 p.m (CEST) for press, artists, thought-leaders, successful entrepreneurs, local celebrities, and social media influencers. The event will feature a global live stream presentation at approximately 6:30pm (CEST) by CEO Todd Shapiro, as well as President Hans Derix and will feature local live artists and DJs including Manuel Broekman, Geza Weisz, Loes van Delft, Amanda van Effrink, aka #GLITZIEGAL and Daan Noppen.

The link to the global livestream will be available on the company’s website www.redlighttruffles.com and/or at glsr.live/iMicrodose

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Thoughtful Brands, Inc. $TBI.ca Signs Supply Agreement with Sweet Earth Holdings Corp. for CBD Dog Treats Line $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $SHRM.ca $RVV.ca $NOVA.ca $CMPS $MMED $PLNT.ca

Posted by AGORACOM-Eric at 8:31 PM on Monday, September 21st, 2020
  • Sweet Earth’s award-winning canine products will be sold under Thoughtful Brands’ Nature’s Exclusive brand, leveraging the Company’s eCommerce capabilities

VANCOUVER, BC / ACCESSWIRE / September 21, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FWB:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands“), a global natural health products and eCommerce technology company, is excited to announce that the company has signed a Supply Agreement with Sweet Earth Holdings Corp. (CSE:SE) (FSE:1KZ1) (“Sweet Earth“), a vertically-integrated hemp company cultivating high-quality CBD products grown in Applegate Valley, Oregon. Sweet Earth is now officially the exclusive CBD dog treat provider to Thoughtful Brands’ direct to consumer brand, Nature’s Exclusive.

The agreement enables the Sweet Earth-produced CBD canine products to utilize Thoughtful Brands’ newly formed Ecommerce Tech LLC, a subsidiary operating a powerful ecommerce software platform designed to maximize customer acquisition and customer service.

The market for pet CBD products is booming: research sponsored earlier this year by RestoraPet and conducted by BDS Analytics and Arcview Market Research projects the pet CBD market to grow five percent faster than the overall CBD market over the next four years, from $64 million in 2018 to $810 million in 2024.

Sweet Earth canine products that will be sold under the Nature’s Exclusive brand include the popular Beef and Cheddar Potato CBD Dog Treats. Sweet Earth’s offerings are Leaping Bunny-certified, the gold-standard in cruelty-free certification for consumer goods signifying no new animal tests were conducted during product development.

“We are thrilled to be working with Sweet Earth, a renowned company whose sophisticated hemp-CBD offerings have long been celebrated,” said Thoughtful Brands CEO Ryan Dean Hoggan. “We are eager to propel the success of their CBD canine products by utilizing our global eCommerce platform and enhanced technology capabilities. We look forward to adding the brand to our portfolio and are hopeful for additional collaborations in the future.”

Building off the success of Nature’s Exclusive and the supply agreement with Sweet Earth, Thoughtful Brands is continuing to expand its portfolio in the nutraceutical and hemp-based CBD product space through the August 2020 acquisition of Golden Path LLC and Wild Mariposa LLC, two direct-to-consumer eCommerce brands offering natural health products throughout the U.S.

Sweet Earth’s CEO, Peter Espig, commented, “We are very excited to work closely with Thoughtful Brands, a company that we feel maintains the hemp industry’s premier brands. The company is well managed, maintains a powerful global platform and enhanced technological capabilities, and constantly researches for new methods of increasing customer service. We look forward to adding our products to Thoughtful Brand’s rapidly growing eCommerce platform, and are hopeful for future collaborations.”

In addition to the above, the Company announces the resignation of Szascha Lim as Chief Financial Officer. The role will be fulfilled once the appropriate person is found.

About Thoughtful Brands Inc.

Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

ON BEHALF OF THE BOARD OF DIRECTORS
THOUGHTFUL BRANDS INC.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected]

Red Light Holland $TRIP.ca Grants Exclusive Access to a Prominent Canadian Production Company and Film Crew to Document the Company in the Netherlands $IPO $SHRM.ca $RVV.ca $CMPS $MMED

Posted by AGORACOM-Eric at 10:04 AM on Monday, September 21st, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png

Toronto, Ontario–(Newsfile Corp. – September 21, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that it has granted a prominent Canadian production company and film crew exclusive access to provide video coverage of the activities of the Company and its Chief Executive Officer, Todd Shapiro, within the Netherlands, leading up to the Company’s previously announced iMicrodose product launch party (the “iMicrodose Launch Party“), scheduled on September 25, 2020, in Amsterdam, the Netherlands. Filming commenced on September 20, 2020 in Horst, the Netherlands (the location of the Company’s production and distribution facility) and will continue through to the iMicrodose Launch Party, covering, among other things, the iMicrodose brand, and the production and distribution facility.

“I’m so grateful for this production company reaching out and offering to document our journey. There’s a ton of hard work that is going on behind the scenes and if all goes according to plan – this will be another piece of earned Media, which hasn’t cost Red Light Holland a dime, to potentially highlight our Company, our tireless efforts and our iMicrodose brand to a much bigger widespread audience,” said Chief Executive Officer and Director of the Company, Todd Shapiro. “Out of respect to the production company’s intellectual property rights, which play a huge role in stimulating innovation and creativity – in this case focusing on Red Light Holland’s early magic truffles production facility, our iMicrodose product launch in the Netherlands, and our expected iMicrodose Launch Party – we’ve mutually agreed to hold off on providing more information for now. However, we look forward to sharing more details in early 2021 about this great exposure opportunity… Now let’s just hope my mug doesn’t get left on the cutting room floor!”

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17 SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-JC at 9:57 AM on Monday, September 21st, 2020

SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.

Red-Light-Holland-Square

Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17

  • Raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16
  • The company offered 0.8 million more ADSs than anticipated
  • At pricing, the company raised 27% more in proceeds than expected

Contributor: Renaissance Capital

COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27% more in proceeds than expected.

COMPASS Pathways plans to list on the Nasdaq under the symbol CMPS. Cowen, Evercore ISI and Berenberg acted as lead managers on the deal.

The company is focusing on using its proprietary formulation of psilocybin, COMP360, in conjunction with psychological support as a way to help individuals who have treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD. COMPASS is currently evaluating COMP360 in conjunction with psychological support in a Phase 2b trial and plans to report data from this trial in late 2021. Classified as a Schedule I drug, psilocybin is considered a serotonergic hallucinogen and is an active ingredient in some species of mushrooms.

The article Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17 originally appeared on IPO investment manager Renaissance Capital’s web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital’s research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital’s Renaissance IPO ETF (symbol: IPO)Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source: https://www.nasdaq.com/articles/can-magic-mushrooms-treat-depression-biotech-compass-pathways-prices-upsized-us-ipo-above

Thoughtful Brands $TBI.ca Enters Binding Term Sheet to Acquire American CBD Extraction Corp. $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $SHRM.ca $RVV.ca $NOVA.ca

Posted by AGORACOM-Eric at 7:46 AM on Monday, September 21st, 2020
  • Agreement paves the way for Thoughtful Brands to become vertically integrated and subsequently reduce operating costs while expanding sales

VANCOUVER, BC / ACCESSWIRE / September 21, 2020 / Thoughtful Brands Inc. (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands“), a global natural health products and eCommerce technology company, is pleased to announce that it has signed a binding term sheet to acquire (the “Proposed Acquisition“) all of the issued and outstanding shares, or all of the assets of, Kentucky-based hemp extraction company American CBD Extraction Corp. (“American CBD“). The Proposed Acquisition is expected to set the stage for Thoughtful Brands to become a fully vertically-integrated CBD company, controlling each aspect of the supply chain, including production, logistics and value chain.

Upon completion of the Proposed Acquisition, the Company will acquire an abundance of hemp biomass along with a fully equipped 41,000 square foot facility with the ability to process more than 1,200 pounds of hemp per day once licensed. Upon completion, Thoughtful Brands would also be able to utilize American CBD’s technological and scientific expertise to enhance the formulations of the Company’s various direct-to-consumer CBD brands, which include Nature’s Exclusive, Sativida and the recently acquired Golden Path and Wild Mariposa. Additionally, the Company plans to sell American CBD’s hemp biomass to support operations in Europe and to other clients worldwide.

“The term sheet with American CBD is an important milestone for the Company because it increases the likelihood of expanded margins and will allow us to launch innovative new products for which we control every step of the process,” said Thoughtful Brands CEO Ryan Hoggan. “Once we’re able to work directly with the team at American CBD and within their state-of-the-art Kentucky facility, we expect to be able to fine-tune and advance our cannabinoid product portfolio.”

Acquisition Details

The Company proposes to acquire all of the issued and outstanding share capital of, or all of the assets of, American CBD in consideration for Cdn$11,000,000, which will be satisfied through the issuance of common shares of the Company (the “Consideration Shares“). The Consideration Shares will be issued to the existing shareholders of American CBD or, in the case of an asset acquisition, directly to American CBD, at a deemed price equivalent to the lesser of (a) Cdn$0.18 per share or (b) the five-day volume-weighted average closing price of the Company’s common shares on the Canadian Securities Exchange for the period preceding closing of the Proposed Acquisition. The Consideration Shares shall be paid upfront and subject to an escrow arrangement, from which 25% of the Consideration Shares will be released on the closing date of the Proposed Acquisition, followed by an additional 25% after each subsequent 90-day period.

In addition to the Consideration Shares, a bonus of Cdn$1,000,000 will be paid to the operating team of American CBD on closing and a Cdn$2,000,000 performance milestone payment will be paid to the operating team of American CBD upon the achievement of production and cumulative online sales of over USD$1,000,000. The bonus and milestone shares will be payable in common shares of the Company based on the five-day volume weighted average closing price of the Company’s shares on the Canadian Securities Exchange immediately prior to the bonus and milestone payments becoming payable.

Closing of the Proposed Acquisition is subject to American CBD: (a) having a minimum cash balance of Cdn$2,000,000, less closing costs related to the Proposed Acquisition (which are not exceed Cdn$40,000); (b) having no debts or liabilities; and (c) having been granted a seat on the Company’s board of directors, all on the closing of the Proposed Acquisition.

The Company is at arms-length from American CBD and its shareholders. The transaction will not constitute a fundamental change for the Company, nor is it expected to result in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange.

Readers are cautioned that the final terms and structure for a transaction between the Company and American CBD have not yet been determined. Completion of any transaction remains subject to negotiation of definitive documentation and satisfaction of conditions set forth above, as well as customary closing conditions for a transaction of this nature. The Proposed Acquisition cannot be completed until these conditions are satisfied. The Company will provide additional information regarding the Proposed Acquisition as soon as it becomes available.

About Thoughtful Brands Inc.

Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe. Through continuous strategic acquisitions, the Company has a strong footprint in the CBD market, as well as the burgeoning psychedelic medicine sector. Thoughtful Brands owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebeul, Germany, where its highly skilled team conducts clinical studies utilizing naturally occurring psilocybin and other compounds found in psychedelics for the treatment of opiate addiction, while planning for future opportunities to create proprietary psilocybin products.

About American CBD Extraction Corp.

From the rich soils of Kentucky, American CBD Extraction Corp. is a Kentucky-based company that produces cannabinoid distillates and isolates, and is positioned to become a significant supplier of hemp-derived extracts. Its location in the eastern part of Kentucky, a place that has been called “The Hemp Capital of the United States,” gives American CBD the privilege to partner with the state’s most experienced farmers to source the highest quality hemp for its products. American CBD is a company founded on dedication, strong work ethic and quality, fulfilling its mission to provide consistent, high-grade and clean hemp-derived CBD oil to meet the growing demand in this evolving marketplace.

ON BEHALF OF THE BOARD OF DIRECTORS

THOUGHTFUL BRANDS INC.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected].

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Red Light Holland’s $TRIP.ca Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics $SHRM.ca $RVV.ca

Posted by AGORACOM-Eric at 9:14 AM on Thursday, September 17th, 2020
Red-Light-Holland-Square

Toronto, Ontario–(Newsfile Corp. – September 17, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that Red Light Holland’s Science and Innovation division, Scarlette Lillie Science and Innovation (“Scarlette Lillie“), has joined the Medical Psychedelics Working Group (“MPWG“), a consortium of drug science experts, leading academics and researchers, policy specialists and industry partners. MPWG’s aim is to create a rational and enlightened approach to psychedelic research and clinical treatment. MPWG will explore innovation within the psychedelic space with a specific focus on how psychedelics can be integrated into primary and secondary healthcare. The Company believes that evidence-based science, sharing data, and strong partnerships are keys to success for the psychedelic community.

“We are elated to join the most respected experts in the industry. To be able to have open communication with leading academics like Professor David Nutt, Dr. Robin Carhart-Harris and Dr. Jo Neill is a major development for Scarlette Lillie Science and Innovation. Access is key in life and having access to the top minds in this sector is something we are all very excited about,” said Red Light Holland CEO and Director, Todd Shapiro.

“When we were approached by Red Light Holland’s Scarlette Lillie Science and Innovation, we were more than happy to include them in this very important working group. We are grateful for their support and we recognize the Company’s genuine and authentic approach to helping make positive change in this world through psilocybin research, education and information. We are thrilled to have Scarlette Lillie join our very MPWG,” stated Professor Jo Neill.

“Both Sarah Hashkes and I are pleased to be able to brainstorm and continue developing these important synergies with our peers in the field of Medical and Science Research to help elevate the Psychedelic Sector as a whole,” added Dr. Joe Geraci, Scarlette Lillie’s Scientific Advisor and CEO of Netramark.

About MPWG

MPWG is a working group of experts, policy makers and scientists. Its primary role is to campaign for the rescheduling of all psychedelic drugs for research and medical purposes.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Berkeley Opens Its Mind to Psychedelics with New Research Centre SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-Eric at 9:57 AM on Wednesday, September 16th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png

Sponsor: Red Light Holland’s goal is to grow, distribute and market a premium brand of magic truffles to the legal, recreational market within the Netherlands, and we can’t wait to shift the existing paradigm to direct further attention to the legal and responsible use of magic truffles. Click Here For More Info

The University of California at Berkeley is getting the dirt on mushrooms.

The school announced on Monday that it will be launching the UC Berkeley Center for the Science of Psychedelics — an institute devoted to expanding and better understanding the effects hallucinogens have on the human brain, according to Marijuana Moment.

“There’s never been a better time to start a centre like this,” said neuroscientist David Presti, one of the founding members of the project. “The renewal of basic and clinical science with psychedelics has catalyzed interest among many people.”

Buoyed by an anonymous US$1.2-million donation, the centre will begin its research by looking at psilocybin — the hallucinogenic component of mushrooms that has received increased attention at other institutions recently for its ability to treat conditions previously thought untreatable.

“Some of these studies have produced striking results in cases that are otherwise resistant to more conventional medical treatment,” said Michael Silver, a neuroscientist and the director of the new centre. “This suggests that psychedelic compounds may offer new hope for people suffering from these disorders.”

Researchers are also working with the university’s graduate theological union to train students to be “facilitators” during psychedelic ceremonies with a focus on the “cultural, contemplative and spiritual care dimensions of psychedelics.”

Study at the centre will be geared toward understanding what happens in the human brain during a psychedelic experience. Researchers hope to gain insight into how visual hallucinations manifest themselves in the brain and the effect they have on a person’s identity, ability to cope with stress and even their social and political attitudes.

“Psychedelic medicines can open a doorway to seeing one’s psyche and connection with the world in new and helpful ways,” Presti said. “That’s been appreciated by shamanic traditions for thousands of years. Science is now exploring new ways to investigate this.”

Currently, psilocybin mushrooms are classified as a Schedule I drug by the FDA, the same category as heroin and cannabis. To be a Schedule I drug means the substance in question holds no medicinal value. As researchers find mushrooms have a positive effect on anxietytreatment-resistant depression, and Seasonal Affective Disorder, that could change.

Like cannabis, psilocybin has a long track record of relative safety among recreational users, and it is not toxic. Unlike some drugs that treat anxiety and other mental conditions, psilocybin is not prone to dependence. But given its hallucinogenic effect, lawmakers may be reticent to allow distribution of the psychedelic drug without more restrictions.

SOURCE: https://theprovince.com/wellness/berkeley-opens-its-mind-to-psychedelics-with-new-research-centre/wcm/3ae4ae9e-7f88-42cf-9e17-ba77318dd03c/